CCM

Catalio Capital Management Portfolio holdings

AUM $479M
1-Year Est. Return 140.7%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+140.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
-$87.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$31.3M
2
+$18.2M
3
+$17.6M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$15.5M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$14.2M

Top Sells

1
+$31.4M
2
+$27.9M
3
+$25M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$23M
5
GILD icon
Gilead Sciences
GILD
+$17.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
26
Abivax
ABVX
$8.36B
$5.25M 1.1%
47,193
-51,321
DYN icon
27
Dyne Therapeutics
DYN
$3.04B
$5.13M 1.07%
282,954
-236,761
ELDN icon
28
Eledon Pharmaceuticals
ELDN
$278M
$5.05M 1.06%
1,639,816
+379,996
KPTI icon
29
Karyopharm Therapeutics
KPTI
$206M
$5M 1.04%
897,709
+754,725
SUPN icon
30
Supernus Pharmaceuticals
SUPN
$2.59B
$3.21M 0.67%
62,019
-195,446
TARA icon
31
Protara Therapeutics
TARA
$248M
$3.02M 0.63%
580,024
-866,230
PHAT icon
32
Phathom Pharmaceuticals
PHAT
$786M
$2.75M 0.58%
247,767
-451,229
NAMS icon
33
NewAmsterdam Pharma
NAMS
$3.82B
$2.67M 0.56%
+83,554
TYRA icon
34
Tyra Biosciences
TYRA
$1.62B
$2.58M 0.54%
+67,285
IMCR icon
35
Immunocore
IMCR
$1.46B
$2.54M 0.53%
+84,352
GUTS icon
36
Fractyl Health
GUTS
$116M
$2.51M 0.53%
5,491,866
HYPR icon
37
Hyperfine
HYPR
$149M
$1.43M 0.3%
1,320,041
MGX icon
38
Metagenomi Therapeutics
MGX
$50.1M
$709K 0.15%
528,993
ATAI icon
39
AtaiBeckley Inc
ATAI
$1.66B
$697K 0.15%
196,858
SNSE icon
40
Sensei Biotherapeutics
SNSE
$22.3M
$464K 0.1%
14,718
OM icon
41
Outset Medical
OM
$87.7M
$454K 0.09%
118,279
ACLX
42
DELISTED
Arcellx
ACLX
– –
-156,109
ADMA icon
43
ADMA Biologics
ADMA
$1.85B
– –
-564,461
FULC icon
44
Fulcrum Therapeutics
FULC
$225M
– –
-201,301
ISRG icon
45
Intuitive Surgical
ISRG
$148B
– –
-27,209
JNJ icon
46
Johnson & Johnson
JNJ
$549B
– –
-120,840
LLY icon
47
Eli Lilly
LLY
$1T
– –
-25,923
OCUL icon
48
Ocular Therapeutix
OCUL
$1.93B
– –
-714,501
OLMA icon
49
Olema Pharmaceuticals
OLMA
$933M
– –
-267,058
REGN icon
50
Regeneron Pharmaceuticals
REGN
$65.9B
– –
-29,797
1
2
3